A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin

References

• Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011; 23:421-9; PMID:21530212; http://dx.doi.org/10.1016/j.coi.2011.03.008
   PubMed Web of Science ®Google Scholar
• Weiner DB. DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine 2008; 26:5073-4; PMID:18652867; http://dx.doi.org/10.1016/j.vaccine.2008.07.024
   PubMed Web of Science ®Google Scholar
• André S, Seed B, Eberle J, Schraut W, Bültmann A, Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 1998; 72:1497-503; PMID:9445053
   PubMed Web of Science ®Google Scholar
• Deml L, Bojak A, Steck S, Graf M, Wild J, Schirmbeck R, Wolf H, Wagner R. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol 2001; 75:10991-1001; PMID:11602739; http://dx.doi.org/10.1128/JVI.75.22.10991-11001.2001
   PubMed Web of Science ®Google Scholar
• Muthumani K, Zhang D, Dayes NS, Hwang DS, Calarota SA, Choo AY, Boyer JD, Weiner DB. Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo. Virology 2003; 314:134-46; PMID:14517067; http://dx.doi.org/10.1016/S0042-6822(03)00459-8
   PubMed Web of Science ®Google Scholar
• Yang JS, Kim JJ, Hwang D, Choo AY, Dang K, Maguire H, Kudchodkar S, Ramanathan MP, Weiner DB. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J Infect Dis 2001; 184:809-16; PMID:11550123; http://dx.doi.org/10.1086/323395
   PubMedGoogle Scholar
• Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, et al.; NIAID HIV Vaccine Trials Network. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis 2013; 208:818-29; PMID:23840043; http://dx.doi.org/10.1093/infdis/jit236
   PubMed Web of Science ®Google Scholar
• Hirao LA, Draghia-Akli R, Prigge JT, Yang M, Satishchandran A, Wu L, Hammarlund E, Khan AS, Babas T, Rhodes L, et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis 2011; 203:95-102; PMID:21148501; http://dx.doi.org/10.1093/infdis/jiq017
   PubMed Web of Science ®Google Scholar
• Konishi E, Kosugi S, Imoto J. Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine 2006; 24:2200-7; PMID:16316713; http://dx.doi.org/10.1016/j.vaccine.2005.11.002
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Yan J, Kutzler M, Kobasa D, Kobinger GP, Khan AS, Greenhouse J, Sardesai NY, Draghia-Akli R, Weiner DB. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS One 2008; 3:e2517; PMID:18575608; http://dx.doi.org/10.1371/journal.pone.0002517
   PubMed Web of Science ®Google Scholar
• Musacchio A, Rodriguez EG, Herrera AM, Quintana D, Muzio V. Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens. Biochem Biophys Res Commun 2001; 282:442-6; PMID:11401479; http://dx.doi.org/10.1006/bbrc.2001.4580
   PubMed Web of Science ®Google Scholar
• Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC, Giffear M, Pankhong P, Khan AS, Broderick KE, et al. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med 2012; 4:ra138; PMID:23052295; http://dx.doi.org/10.1126/scitranslmed.3004414
   PubMedGoogle Scholar
• Hooper JW, Custer DM, Smith J, Wahl-Jensen V. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 2006; 347:208-16; PMID:16378630; http://dx.doi.org/10.1016/j.virol.2005.11.035
   PubMed Web of Science ®Google Scholar
• Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Vaccine 2008; 26:5177-81; PMID:18482782; http://dx.doi.org/10.1016/j.vaccine.2008.03.097
   PubMed Web of Science ®Google Scholar
• Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 2000; 266:329-39; PMID:10639319; http://dx.doi.org/10.1006/viro.1999.0096
   PubMed Web of Science ®Google Scholar
• Gasparić M, Rubio I, Thönes N, Gissmann L, Müller M. Prophylactic DNA immunization against multiple papillomavirus types. Vaccine 2007; 25:4540-53; PMID:17485151; http://dx.doi.org/10.1016/j.vaccine.2007.04.001
   PubMed Web of Science ®Google Scholar
• Kjerrström A, Hinkula J, Engström G, Ovod V, Krohn K, Benthin R, Wahren B. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines. Virology 2001; 284:46-61; PMID:11352667; http://dx.doi.org/10.1006/viro.2001.0905
   PubMed Web of Science ®Google Scholar
• Zhu W, Wu C, Deng W, Pei R, Wang Y, Cao L, Qin B, Lu M, Chen X. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. PLoS One 2012; 7:e45146; PMID:23024803; http://dx.doi.org/10.1371/journal.pone.0045146
   PubMed Web of Science ®Google Scholar
• Böckl K, Wild J, Bredl S, Kindsmüller K, Köstler J, Wagner R. Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine. PLoS One 2012; 7:e34723; PMID:22509350; http://dx.doi.org/10.1371/journal.pone.0034723
   PubMed Web of Science ®Google Scholar
• Sugar IP, Förster W, Neumann E. Model of cell electrofusion. Membrane electroporation, pore coalescence and percolation. Biophys Chem 1987; 26:321-35; PMID:3607233; http://dx.doi.org/10.1016/0301-4622(87)80033-9
   PubMed Web of Science ®Google Scholar
• Sugar IP, Neumann E. Stochastic model for electric field-induced membrane pores. Electroporation. Biophys Chem 1984; 19:211-25; PMID:6722274; http://dx.doi.org/10.1016/0301-4622(84)87003-9
   PubMed Web of Science ®Google Scholar
• Bråve A, Ljungberg K, Boberg A, Rollman E, Isaguliants M, Lundgren B, Blomberg P, Hinkula J, Wahren B. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery. Mol Ther 2005; 12:1197-205; PMID:16112909; http://dx.doi.org/10.1016/j.ymthe.2005.06.473
   PubMed Web of Science ®Google Scholar
• Otten G, Schaefer M, Doe B, Liu H, Srivastava I, zur Megede J, O’Hagan D, Donnelly J, Widera G, Rabussay D, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 2004; 22:2489-93; PMID:15193413; http://dx.doi.org/10.1016/j.vaccine.2003.11.073
   PubMed Web of Science ®Google Scholar
• Prud’homme GJ, Draghia-Akli R, Wang Q. Plasmid-based gene therapy of diabetes mellitus. Gene Ther 2007; 14:553-64; PMID:17215847; http://dx.doi.org/10.1038/sj.gt.3302907
   PubMed Web of Science ®Google Scholar
• Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, Chen M, Leung L, Otten GR, Thudium K, Selby MJ, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164:4635-40; PMID:10779767; http://dx.doi.org/10.4049/jimmunol.164.9.4635
   PubMed Web of Science ®Google Scholar
• Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6:508-14; PMID:10476210; http://dx.doi.org/10.1038/sj.gt.3300847
   PubMed Web of Science ®Google Scholar
• Otten GR, Schaefer M, Doe B, Liu H, Megede JZ, Donnelly J, Rabussay D, Barnett S, Ulmer JB. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 2006; 24:4503-9; PMID:16181711; http://dx.doi.org/10.1016/j.vaccine.2005.08.017
   PubMed Web of Science ®Google Scholar
• El-Kamary SS, Billington M, Deitz S, Colby E, Rhinehart H, Wu Y, Blackwelder W, Edelman R, Lee A, King A. Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. Mol Ther 2012; 20:214-20; PMID:22068424; http://dx.doi.org/10.1038/mt.2011.235
   PubMed Web of Science ®Google Scholar
• Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther 2011; 18:258-65; PMID:20962869; http://dx.doi.org/10.1038/gt.2010.137
   PubMed Web of Science ®Google Scholar
• Broderick KE, Chan A, Lin F, Shen X, Kichaev G, Khan AS, Aubin J, Zimmermann TS, Sardesai NY. Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. Mol Ther Nucleic Acids 2012; 1:e11; PMID:23344722; http://dx.doi.org/10.1038/mtna.2012.1
   PubMedGoogle Scholar
• Shen X, Söderholm J, Lin F, Kobinger G, Bello A, Gregg DA, Broderick KE, Sardesai NY. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Vaccine 2012; 30:6946-54; PMID:22406460; http://dx.doi.org/10.1016/j.vaccine.2012.02.071
   PubMed Web of Science ®Google Scholar
• Lin F, Shen X, Kichaev G, Mendoza JM, Yang M, Armendi P, Yan J, Kobinger GP, Bello AJ, Khan A, et al. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device. Hum Gene Ther Methods 2012
   PubMed Web of Science ®Google Scholar
• Mendoza J, Amante D, Kichaev G, Knott C, Kiosses W, Smith T, Sardesai N, Broderick K. Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation. Vaccines 2013; 1:384-97; http://dx.doi.org/10.3390/vaccines1030384
   Google Scholar
• Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, King AD, Stout RR, Blomberg P, Höglund U, et al. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine 2010; 28:8203-9; PMID:20951666; http://dx.doi.org/10.1016/j.vaccine.2010.08.108
   PubMed Web of Science ®Google Scholar
• Donate A, Coppola D, Cruz Y, Heller R. Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One 2011; 6:e19181; PMID:21559474; http://dx.doi.org/10.1371/journal.pone.0019181
   PubMed Web of Science ®Google Scholar
• Eriksson F, Tötterman T, Maltais AK, Pisa P, Yachnin J. DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer. Vaccine 2013; 31:3843-8; PMID:23831327; http://dx.doi.org/10.1016/j.vaccine.2013.06.063
   PubMed Web of Science ®Google Scholar
• Gothelf A, Gehl J. What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother 2012; 8:1694-702; PMID:23111168; http://dx.doi.org/10.4161/hv.22062
   PubMed Web of Science ®Google Scholar
• Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, King A, Wahren B. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines. Genet Vaccines Ther 2012; 10:5; PMID:22873174; http://dx.doi.org/10.1186/1479-0556-10-5
   PubMedGoogle Scholar
• Krotova O, Starodubova E, Petkov S, Kostic L, Agapkina J, Hallengärd D, Viklund A, Latyshev O, Gelius E, Dillenbeck T, et al. Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells. PLoS One 2013; 8:e62720; PMID:23667513; http://dx.doi.org/10.1371/journal.pone.0062720
   PubMed Web of Science ®Google Scholar
• Cu Y, Broderick K, Banerjee K, Hickman J, Otten G, Barnett S, Kichaev G, Sardesai N, Ulmer J, Geall A. Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ. Vaccines 2013; 1:367-83; http://dx.doi.org/10.3390/vaccines1030367
   Google Scholar
• Cai Y, Rodriguez S, Rameswaran R, Draghia-Akli R, Juba RJ Jr., Hebel H. Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage. Vaccine 2010; 28:2046-52; PMID:19896448; http://dx.doi.org/10.1016/j.vaccine.2009.10.057
   PubMed Web of Science ®Google Scholar